Skin cancer risk in patients with BRCA mutations

• Lucy J. Navsaria, MBBCh, BAO,
• Allen M. Haas, MS,
• Jessica L. Corredor, MS,
• Banu K. Arun, MD,
• Sharon H. Giordano, MD,
• Kevin T. Nead, MD, MPhil,
• Mackenzie R. Wehner, MD, MPhil

Affiliations

Lucy J. Navsaria, MBBCh, BAO

Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas

Allen M. Haas, MS

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Jessica L. Corredor, MS

Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, Texas

Banu K. Arun, MD

Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Sharon H. Giordano, MD

Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Kevin T. Nead, MD, MPhil

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston

Mackenzie R. Wehner, MD, MPhil

Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Correspondence to: Mackenzie R. Wehner, MD, MPhil, Assistant Professor, Department of Health Services Research, Department of Dermatology, University of Texas MD Anderson Cancer Center, 1400 Pressler St Unit 1444, Houston, TX 77030